Pharvaris N.V. (PHVS) reporting calendar
Pharvaris N.V. files periodic reports with the SEC as PHVS on Nasdaq. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 2 Apr 2026
- Reports on record
- 6
Open PHVS market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 2 Apr 2026 | 92 days | 0001830487-26-000013 |
| 20-F | 31 Dec 2024 | 7 Apr 2025 | 97 days | 0000950170-25-051347 |
| 20-F | 31 Dec 2023 | 10 Apr 2024 | 101 days | 0000950170-24-043358 |
| 20-F | 31 Dec 2022 | 5 Apr 2023 | 95 days | 0000950170-23-011842 |
| 20-F | 31 Dec 2021 | 29 Mar 2022 | 88 days | 0001564590-22-012066 |
| 20-F | 31 Dec 2020 | 29 Apr 2021 | 119 days | 0001193125-21-140476 |
Source: SEC EDGAR company submissions for CIK 0001830487. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.